Discover the key to ideal health with HYGIA Nutrients
The phytocannabinoids found in our Hemp Extract is a non-psychoactive substance found only in Cannabis plants. There is growing scientific support for the proposition this phytocannabinoid is a valuable therapeutic for a variety of conditions, from inflammation and pain to diabetes, ulcerative colitis, atherosclerosis and heart disease. Phytocannabinoids are particularly abundant in industrial hemp.
Industrial hemp is defined as a cannabis plant with its parts (stems, leaves, flowers) containing no more than 0.3 percent of psychoactive cannabinoids; in other words, minute, sub-psychoactive levels (i.e., not enough to “get high”) on a dry weight basis under Section 7606 of the Federal Farm Bill, or the Agricultural Act of 2014.
The Section 7606 “Legitimacy of Industrial Hemp Research” provision exempts industrial hemp from existing legal prohibitions when grown through approved programs in the 10 states where industrial hemp is already a legal crop: California, Colorado, Kentucky, Maine, Montana, North Dakota, Oregon, Vermont, Washington and West Virginia. Another 20 states now allow or are on the verge of allowing industrial hemp cultivation.
Phytocannabinoids are fat-soluble and thus can be extracted from the leaves and immature flowers of industrial hemp plants or cannabis with ethanol; other solvents used to dissolve oils, grease and waxes; carbon dioxide in its pressurized liquid (supercritical) form; and proprietary, patent-protected nanotechnology owned by ANANDA Scientific. Purified Hemp Extract can be obtained by passing it through tall columns composed of refined silica, a medium commonly used in separation science. Pure phytocannabinoids in crystalline form can also be acquired via its precipitation directly from extracts.
Phytocannabinoids are found in both cannabis and industrial hemp. Extracts of industrial hemp and cannabis particularly differ in terms of their psychoactive cannabinoid content. Industrial hemp inherently has very little psychoactive phytocannabinoids; thus, are not associated with a “high” or psychoactivity.
High-quality Hemp Extract (like Hygia) is of sufficient purity for dependable use in chemical analysis, chemical reactions, physical testing, and functional food or medicinal use. Its purity typically exceeds 98 percent, and analytical methods used for such a determination — such as high-performance liquid chromatography — are based on standard test procedures, for which updated improvements are employed once available to achieve a higher degree of reliability. Of course, psychoactive phytocannabinoids should only be present in miniscule amounts, preferably much less than the 0.3 percent maximum. Using hexane and other toxic, Class 2 solvents for extraction and purification per 62 FR 67377 of the U.S. Federal Register is unacceptable for making CBD as a food additive because of inherent toxicities. High-quality CBD is typically accompanied by an appropriately detailed certificate of analysis (CoA).
Published scientific and medical reports indicate CBD could ultimately prove valuable for:
• Alleviating pain, without nasty side effects, where other analgesics have excessive risk or adverse physiological consequences, or fail
• Reducing opiate use—thus creating greater mental clarity, less addiction and fewer overdose deaths
• Decreasing inflammation without the harmful effects of non-steroidal anti-inflammatory drugs (NSAIDs) or steroids
• Stabilizing, reversing or even preventing both types of diabetes
• Inhibiting or shrinking cancerous tumors
• Limiting damage from a heart attack
• Shrinking the arterial plaques caused by atherosclerosis
• Relieving Crohn’s disease and ulcerative colitis
• Improving mental disorders like autism, post-traumatic stress disorder (PTSD) and anxiety
• Easing motor diseases such as multiple sclerosis (MS) and Lou Gehrig’s disease (ALS)
Oral administration, or taking by mouth, is the delivery method overwhelmingly preferred by consumers and healthcare practitioners. It is very convenient, non-invasive and requires no special training.
In this instance, bioavailability refers to the ability of phytocannabinoids to get into the bloodstream after being taken by mouth. Phytocannabinoid bioavailability is inherently low. It is a major impediment to successfully using it in pharmaceutic and nutraceutical preparations. Minor amounts, 5 to 6 percent, get into the body with oral administration, and the rest is wasted. This inefficiency can make for unpredictable outcomes, unless exorbitant (and thus, expensive) amounts are used.
A proprietary nanotechnology (the engineering of functional systems at dimensions less than 1/10,000 the width of a human hair) developed by ANANDA Scientific overcomes the challenges associated with oral administration. The unique process makes it possible for higher amounts of phytocannabinoids to get into the bloodstream, thus allowing for predictable results from its use. This method also renders phytocannabinoids distinctively water soluble. This contrasts other preparations, which cannot be dissolved in water.